title: Treatment of primary autoimmune thrombocytopenia (AITP) [1].
authors: Hagaziekenhuis, The Hague, The Netherlands. m.schipperus@hagaziekenhuis.nl
authors: M R
authors: MR
authors: Schipperus
authors: R
authors: R
authors: Fijnheer
authors: I
authors: I
authors: Pabinger
authors: B
authors: B
authors: Godeau
authors: M
authors: M
authors: Michel
authors: Y
authors: Y
authors: Tomiyama
authors: P
authors: P
authors: Imbach
authors: A
authors: A
authors: Cuker
authors: B
authors: B
authors: Cines
authors: S
authors: S
authors: Panzer
authors: H W
authors: HW
authors: Reesink
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D053628:Receptors, Thrombopoietin / Q000819:agonists; D034061:Thrombopoiesis
chemical_list: D053628:Receptors, Thrombopoietin; C082218:MPL protein, human